- Home
- SLQT vs COGT Comparison
SLQT vs COGT Comparison
Compare SLQT & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- COGT
- Stock Information
- Founded
- SLQT 1999
- COGT 2014
- Country
- SLQT United States
- COGT United States
- Employees
- SLQT N/A
- COGT N/A
- Industry
- SLQT Specialty Insurers
- COGT Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- COGT Health Care
- Exchange
- SLQT Nasdaq
- COGT Nasdaq
- Market Cap
- SLQT 566.4M
- COGT 555.6M
- IPO Year
- SLQT 2020
- COGT 2018
- Fundamental
- Price
- SLQT $2.15
- COGT $5.61
- Analyst Decision
- SLQT Hold
- COGT Buy
- Analyst Count
- SLQT 2
- COGT 6
- Target Price
- SLQT $3.38
- COGT $15.20
- AVG Volume (30 Days)
- SLQT 1.2M
- COGT 1.3M
- Earning Date
- SLQT 05-12-2025
- COGT 05-06-2025
- Dividend Yield
- SLQT N/A
- COGT N/A
- EPS Growth
- SLQT N/A
- COGT N/A
- EPS
- SLQT N/A
- COGT N/A
- Revenue
- SLQT $1,488,701,000.00
- COGT N/A
- Revenue This Year
- SLQT $15.45
- COGT N/A
- Revenue Next Year
- SLQT $12.78
- COGT N/A
- P/E Ratio
- SLQT N/A
- COGT N/A
- Revenue Growth
- SLQT 20.41
- COGT N/A
- 52 Week Low
- SLQT $1.62
- COGT $3.72
- 52 Week High
- SLQT $6.86
- COGT $12.61
- Technical
- Relative Strength Index (RSI)
- SLQT 31.57
- COGT 58.85
- Support Level
- SLQT $2.11
- COGT $4.80
- Resistance Level
- SLQT $2.23
- COGT $4.99
- Average True Range (ATR)
- SLQT 0.10
- COGT 0.38
- MACD
- SLQT 0.02
- COGT 0.09
- Stochastic Oscillator
- SLQT 10.13
- COGT 68.39
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.